Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Glucosidase inhibitors block enzymes that cleave glucose units from oligosaccharides, disaccharides and glycoproteins. Intestinal α-glucosidases break down dietary carbohydrates, so their inhibitors are used to study postprandial glucose uptake. Acarbose, a pseudo-oligosaccharide, and miglitol, an iminosugar, are standard inhibitors of these enzymes. In the endoplasmic reticulum, glucosidases I and II trim glucose residues from newly attached N-linked glycans. Trimming and later reglucosylation control glycoprotein binding to the chaperone calnexin, as reported in 1995. Deoxynojirimycin and celgosivir inhibit these processing glucosidases and are used in glycoprotein folding and virology research. Miglustat hydrochloride, an N-alkylated iminosugar, also inhibits glucosylceramide synthase in glycosphingolipid research.
7β-Hydroxybufalin is a bufadienolide that acts as a potent inhibitor of α-glucosidase and acetylcholinesterase. Isolated from the venom of Bufo bufo gargarizans, this compound demonstrates significant biological activity relevant to the modulation of carbohydrate and neurotransmitter metabolism. 7β-Hydroxybufalin is utilized in research applications focused on metabolic disorders and neurodegenerative diseases.
Out of stock
All 3 sizes
Synonyms: Homonojirimycin
α-Homonojirimycin is a potent inhibitor of α-glucosidase, an enzyme involved in carbohydrate metabolism. By blocking α-glucosidase activity, it effectively modulates glucose absorption, making it a valuable compound for research in diabetes and metabolic disorder studies. Its inhibitory properties are also applicable in exploring the roles of glycosidases in various biological processes.
4-Ethoxy-5,8-dihydroxy-3,4-dihydronaphthalen-1(2H)-one is a naphthalene derivative that functions as a weak α-glucosidase inhibitor. This compound, which can be isolated from the leaves of Cyclocarya paliurus, is relevant in the study of diabetes management. Its inhibitory activity on α-glucosidase suggests potential applications in carbohydrate metabolism research and glycemic control studies.
Out of stock
All 3 sizes
α-Glucosidase-IN-16 is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 3.28 μM. This compound effectively lowers blood glucose levels in Streptozotocin-induced diabetic rats, demonstrating significant antidiabetic properties. Its use in research facilitates the exploration of therapeutic strategies for managing diabetes and related metabolic disorders.
α-Glucosidase-IN-54 is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 0.011 mM. This compound, derived from Syzygium jambos, is valuable for research focused on glucose metabolism and diabetes management. Its inhibitory action makes it a useful tool for studying the mechanisms of carbohydrate digestion and potential therapeutic interventions for hyperglycemia.
Out of stock
All 3 sizes
α-Glucosidase-IN-29 is a potent inhibitor of α-glucosidase, displaying an IC50 value of 1.21 μM and a Ki value of 1.80 μM. This compound is primarily utilized in research focused on diabetes and associated metabolic disorders, where modulation of carbohydrate absorption is critical. Its mechanistic action allows for potential exploration in understanding the therapeutic effects against glycemic control and related physiological impacts.
Out of stock
All 3 sizes
EB-0176 is a potent inhibitor of endoplasmic reticulum α-glucosidases I and II, exhibiting IC50 values of 0.6439 μM and 0.0011 μM, respectively. This N-substituted derivative of valiolamine demonstrates broad-spectrum antiviral activity, positioning it as a valuable tool for research into antiviral agents targeting both existing and emerging viruses. Its ability to inhibit key glycosylation processes makes it significant for studies in virology and therapeutic development.
Out of stock
All 3 sizes
Synonyms: Flavosativaside
Vitexin-2''-O-glucoside is a selective inhibitor of alpha-glucosidase, primarily extracted from flavonoids in hawthorn leaves. It reversibly inhibits α-glucosidase activity at the brush border of the small intestine, demonstrating a potent inhibitory effect. This compound is widely utilized in research related to type 2 diabetes and may serve as a promising candidate for therapeutic development in glycemic control.
PBI-6DNJ is a potent α-glucosidase inhibitor that functions as a multivalent glycosidase inhibitor. It demonstrates significant inhibitory activity against mouse α-glucosidase, with an affinity constant (Ki) of 0.14 μM. The compound also exhibits notable hypoglycemic effects, making it a valuable tool for research related to type 2 diabetes.
Out of stock
All 3 sizes
16-Oxoserratenediol is a serratene-type triterpenoid that functions as an α-glucosidase inhibitor, demonstrating an inhibition rate of 43.93% at a concentration of 100 μM. This compound is derived from Lycopodium cernuum L. and is primarily utilized in research related to diabetes management and metabolic disorders. Its mechanism of action contributes to the regulation of carbohydrate metabolism, making it a valuable tool for studying glycemic control in various biological contexts.
Deacylhericene is an α-glucosidase inhibitor that demonstrates a potent inhibitory effect with an IC50 of 12.5 μM. This compound functions by effectively reducing the activity of α-glucosidase, making it a valuable reagent for studying carbohydrate metabolism. Its application is particularly relevant in diabetes research and the exploration of glycemic control mechanisms.
Out of stock
All 3 sizes
2,3-Indolobetulonic acid functions as an α-glucosidase inhibitor, exhibiting an IC50 of 1.8 µM. This triterpenoid compound is significant in research related to glucose metabolism and diabetes management. It is valuable for studies focusing on carbohydrate digestion and its modulation within metabolic pathways.
(-)-6β-Hydroxy-5β,8β,9β,10α-cleroda-3,13-dien-16,15-olid-18-oic acid serves as a potent α-Glucosidase inhibitor, demonstrating an IC50 value of 577.7 µM. This compound is valuable in research focused on carbohydrate metabolism and the management of postprandial hyperglycemia. Its ability to modulate α-glucosidase activity makes it a useful tool in studies related to diabetes and metabolic disorders.
α-Glucosidase-IN-38 is a potent inhibitor of α-glucosidase, with an IC50 value of 12.44±0.38 μM. This compound is significant for its role in the management of Diabetes Mellitus (DM) by reducing carbohydrate absorption in the intestines. It is useful for research applications focused on metabolic disorders and the development of diabetes therapies.
Out of stock
All 3 sizes
α-Glucosidase-IN-24 is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 451 μM. This compound is derived from the plant Swertia kouitchensis and is primarily used in research to study carbohydrate metabolism and its implications in conditions such as diabetes and obesity. Its inhibitory action on α-glucosidase makes it a valuable tool for exploring therapeutic strategies targeting metabolic disorders.
α-Glucosidase-IN-113 is a specific inhibitor of α-glucosidase, exhibiting an IC50 of 17.52 μM. This compound demonstrates antiglycating properties and effectively inhibits the formation of advanced glycation end-products. Its applications include research into type 2 diabetes and related metabolic disorders.
Out of stock
All 3 sizes
N-Formyldehydroanonaine is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 104.6 μM against yeast α-glucosidase. This compound is useful for research into diabetes mellitus, providing insights into the management of postprandial blood sugar levels through inhibition of carbohydrate breakdown.
Out of stock
All 3 sizes
Prunetin 5-O-β-D-glucopyranoside is an isoflavone that functions as a potent uncompetitive inhibitor of α-glucosidase, exhibiting an IC50 of 56.05 μg/mL. This compound is derived from extracts of Potentilla astracanica and plays a significant role in modulating carbohydrate metabolism. It is particularly relevant for research applications focused on type-2 diabetes and the management of postprandial hyperglycemia.
α-Glucosidase-IN-25 is a competitive inhibitor of α-glucosidase, exhibiting an IC50 value of 1.19 μM. This compound serves as a valuable tool in anti-diabetic research by inhibiting carbohydrate absorption and regulating postprandial blood glucose levels. Its ability to modulate α-glucosidase activity makes it a promising candidate for the development of therapeutic strategies targeting diabetes management.
Out of stock
All 3 sizes
α-Glucosidase-IN-14 is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 5.22 μM. This compound is valuable for studying carbohydrate metabolism and related disorders, particularly in the context of diabetes management. Its ability to inhibit α-glucosidase makes it a useful tool in pharmacological research aimed at developing therapies that modulate glucose absorption and metabolism.
Out of stock
All 3 sizes
N-(E)-Caffeoyldopamine is an α-glucosidase inhibitor derived from Clerodendranthus Spicatus, demonstrating an inhibitory activity of 53.73% against the enzyme. This compound has significant potential for applications in diabetes research, where it can be utilized to explore mechanisms of glucose metabolism and regulation. Its role in modulating α-glucosidase activity makes it a valuable tool for studying carbohydrate absorption and related metabolic disorders.
α-Glucosidase-IN-70 is a potent α-glucosidase inhibitor with an IC50 of 31.1 μM, derived from the traditional Chinese herbal medicine Swertia mussotii. This compound is valuable for investigating the modulation of carbohydrate metabolism, particularly in the context of diabetes research. Its inhibitory action on α-glucosidase makes it a suitable candidate for further studies exploring therapeutic strategies to manage postprandial hyperglycemia.
α-Glucosidase-IN-111 is a selective inhibitor of α-glucosidase, demonstrating an IC50 of 34.99 μg/mL. In addition to its inhibitory effects on α-glucosidase, it exhibits strong antioxidant properties, effectively scavenging DPPH and ABTS free radicals with IC50 values of 5.33 and 5.84 μg/mL, respectively. This compound is valuable for research focused on type 2 diabetes and related metabolic disorders, making it a useful tool for studying glycemic control and oxidative stress mechanisms.
Out of stock
All 3 sizes
Valibose is an alpha-glucosidase inhibitor that plays a crucial role in regulating carbohydrate metabolism. It has been shown to improve metabolic disorders related to glucose and lipid levels, as well as alleviate nephropathy in Streptozotocin-induced diabetic rat models. This compound is valuable for research focused on diabetes and associated metabolic conditions.
Chrysin 6-C-arabinoside 8-C-glucoside is an α±-glucosidase inhibitor that demonstrates significant potential in the management of type 2 diabetes. By inhibiting α-glucosidase activity, this compound can effectively reduce carbohydrate digestion and absorption, potentially leading to improved glycemic control. Its biological activity makes it a valuable tool for research into metabolic disorders and the development of antidiabetic therapies.
